ClinicalTrials.gov record
Recruiting Phase 3 Interventional

A Study to Evaluate the Efficacy and Safety of Sotagliflozin in Symptomatic Obstructive and Non-obstructive Hypertrophic Cardiomyopathy

ClinicalTrials.gov ID: NCT06481891

Public ClinicalTrials.gov record NCT06481891. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 19, 2026, 5:16 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of SOtaglifloziN in symptomATic Obstructive And Non-obstructive Hypertrophic CardioMyopathy (SONATA-HCM)

Study identification

NCT ID
NCT06481891
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Lexicon Pharmaceuticals
Industry
Enrollment
500 participants

Conditions and interventions

Interventions

  • Placebo Drug
  • Sotagliflozin Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 23, 2024
Primary completion
Jun 30, 2026
Completion
Jul 31, 2026
Last update posted
May 17, 2026

2024 – 2026

United States locations

U.S. sites
33
U.S. states
23
U.S. cities
31
Facility City State ZIP Site status
Lexicon Investigational Site (4041) Phoenix Arizona 85054 Recruiting
Lexicon Investigational Site (4037) Scottsdale Arizona 85260 Recruiting
Lexicon Investigational Site (4012) Los Angeles California 90048 Recruiting
Lexicon Investigational Site (4035) Pomona California 91767 Recruiting
Lexicon Investigational Site (4044) San Francisco California 94143 Recruiting
Lexicon Investigational Site (4046) Jacksonville Florida 32224 Recruiting
Lexicon Investigational Site (4034) Orlando Florida 32804 Recruiting
Lexicon Investigational Site (4018) Atlanta Georgia 30322 Recruiting
Lexicon Investigational Site (4033) Evanston Illinois 60208 Recruiting
Lexicon Investigational Site (4036) Merrillville Indiana 46410 Recruiting
Lexicon Investigational Site (4021) Baltimore Maryland 21218 Recruiting
Lexicon Investigational Site (4016) Boston Massachusetts 02115 Recruiting
Lexicon Investigational Site (4042) Boston Massachusetts 02118 Recruiting
Lexicon Investigational Site (4028) Ann Arbor Michigan 48109 Recruiting
Lexicon Investigational Site (4038) Grand Rapids Michigan 49525 Recruiting
Lexicon Investigational Site (4027) Rochester Minnesota 55905 Recruiting
Lexicon Investigational Site (4013) St Louis Missouri 63110 Recruiting
Lexicon Investigational Site (4029) Morristown New Jersey 07960 Recruiting
Lexicon Investigational Site (4039) Manhasset New York 11030 Recruiting
Lexicon Investigational Site (4043) New York New York 10016 Recruiting
Lexicon Investigational Site (4026) Morrisville North Carolina 27560 Recruiting
Lexicon Investigational Site (4031) Cincinnati Ohio 45219 Recruiting
Lexicon Investigational Site (4017) Cleveland Ohio 44195 Recruiting
Lexicon Investigational Site (4024) Tulsa Oklahoma 74104 Recruiting
Lexicon Investigational Site (4015) Portland Oregon 97239 Recruiting
Lexicon Investigational Site (4011) Philadelphia Pennsylvania 19104 Recruiting
Lexicon Investigational Site (4019) Germantown Tennessee 38138 Recruiting
Lexicon Investigational Stie (4014) Houston Texas 77030 Recruiting
Lexicon Investigational Site (4032) Charlottesville Virginia 22908 Recruiting
Lexicon Investigational Site (4045) Seattle Washington 98101 Recruiting
Lexicon Investigational Site (4010) Seattle Washington 98195 Recruiting
Lexicon Investigational Site (4022) Marshfield Wisconsin 54449 Recruiting
Lexicon Investigational Site (4040) Milwaukee Wisconsin 53215 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 75 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06481891, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 17, 2026 · Synced May 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06481891 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →